Search - tctmd.com

Displaying 161 - 180 of 627

Sort: Relevancy | Date

Presentation ESC 2022

Acetazolamide in Decompensated heart failure with Volume OveRload (ADVOR)

Presenter: Wilfried Mullens

August 29, 2022

Presentation ESC 2022

Treatment In the Morning or Evening: The TIME Study Results

Presenter: Thomas MacDonald

August 29, 2022

Presentation ESC 2022

A Polypill Strategy in Secondary Prevention: Results of the SECURE Trial

Presenter: Valentin Fuster

August 29, 2022

News Conference News ESC 2022

Less Death, Major Bleeding With Transradial Access: Meta-analysis

Michael O'Riordan

August 29, 2022

News Conference News ESC 2022

CMR, PET Similar for Identifying Coronary Disease After CTA: Dan-NICAD 2

Todd Neale

August 29, 2022

News Conference News ESC 2022

P2Y12 Inhibitors Top Aspirin for Long-term Secondary Prevention: PANTHER

Todd Neale

August 29, 2022

News Conference News ESC 2022

ARBs Halve Rate of Aortic Root Enlargement in Marfan: Meta-analysis

Shelley Wood

August 29, 2022

News Conference News ESC 2022

Only Very Small Risk of Muscle Symptoms With Statins: CTT Collaboration

Michael O'Riordan

August 29, 2022

Presentation ESC 2022

FFR vs. Angiography-guided PCI in AMI with multivessel disease

Presenter: Joo-Yong Hahn

August 29, 2022

Presentation ESC 2022

International Study Of Comparative Health Effectiveness With Medical And Invasive Approaches - Chronic Kidney Disease EXTENDed Follow-up: Survival at 5 years of Follow-up

Presenter: Sripal Bangalore

August 29, 2022

Presentation ESC 2022

Long-Term Evolocumab in Patients with Established Atherosclerotic Cardiovascular Disease: Primary Results of the FOURIER-OLE (Open-Label Extension) Studies

Presenter: Michelle L. O’Donoghue

August 29, 2022

Presentation ESC 2022

Sacubitril/Valsartan Versus Ramipril for Patients with Acute Myocardial Infarction: Win-ratio Analysis of the PARADISE-MI Trial

Presenter: Otavio Berwanger

August 29, 2022

Presentation ESC 2022

Impact on Mortality and Major Bleeding of Radial Versus Femoral Artery Access for Coronary Angiography or Percutaneous Coronary Intervention: a meta-analysis of individual patient data from seven multicenter randomized clinical trials

Presenter: Giuseppe Gargiulo

August 29, 2022

Presentation ESC 2022

Colchicine and Aspirin in Community Patients with COVID-19: An Open-label, Factorial, Randomized Trial

Presenter: John Eikelboom

August 29, 2022

Presentation ESC 2022

Efficacy and Safety of the Oral Factor XIa Inhibitor, Asundexian, Added to Dual Antiplatelet Therapy After an Acute Myocardial Infarction

Presenter: John H. Alexander

August 28, 2022

Presentation ESC 2022

Smartphone-based screening for atrial fibrillation (eBRAVE-AF) – A pragmatic siteless digital randomized clinical trial

Presenter: Axel Bauer

August 28, 2022

Presentation ESC 2022

Coronary Atherosclerotic Plaque Activity and Future Coronary Events

Presenter: David Newby

August 28, 2022

Presentation ESC 2022

Colchicine and Rivaroxaban Plus Aspirin in Patients Hospitalized with COVID-19: A Factorial, Randomized, Open Trial

Presenter: Sanjit Jolly

August 28, 2022

News Conference News ESC 2022

‘Hot’ Plaque on Noninvasive PET May Presage MI, CV Death: PRE18FFIR

Shelley Wood

August 28, 2022

News Conference News ESC 2022

INVICTUS: More Deaths, Stroke With Rivaroxaban in Rheumatic Heart Disease AF

Michael O'Riordan

August 28, 2022

Advertisement

Acetazolamide in Decompensated heart failure with Volume OveRload (ADVOR)

Treatment In the Morning or Evening: The TIME Study Results

A Polypill Strategy in Secondary Prevention: Results of the SECURE Trial

Less Death, Major Bleeding With Transradial Access: Meta-analysis

CMR, PET Similar for Identifying Coronary Disease After CTA: Dan-NICAD 2

P2Y12 Inhibitors Top Aspirin for Long-term Secondary Prevention: PANTHER

ARBs Halve Rate of Aortic Root Enlargement in Marfan: Meta-analysis

Only Very Small Risk of Muscle Symptoms With Statins: CTT Collaboration

FFR vs. Angiography-guided PCI in AMI with multivessel disease

International Study Of Comparative Health Effectiveness With Medical And Invasive Approaches - Chronic Kidney Disease EXTENDed Follow-up: Survival at 5 years of Follow-up

Long-Term Evolocumab in Patients with Established Atherosclerotic Cardiovascular Disease: Primary Results of the FOURIER-OLE (Open-Label Extension) Studies

Sacubitril/Valsartan Versus Ramipril for Patients with Acute Myocardial Infarction: Win-ratio Analysis of the PARADISE-MI Trial

Impact on Mortality and Major Bleeding of Radial Versus Femoral Artery Access for Coronary Angiography or Percutaneous Coronary Intervention: a meta-analysis of individual patient data from seven multicenter randomized clinical trials

Colchicine and Aspirin in Community Patients with COVID-19: An Open-label, Factorial, Randomized Trial

Efficacy and Safety of the Oral Factor XIa Inhibitor, Asundexian, Added to Dual Antiplatelet Therapy After an Acute Myocardial Infarction

Smartphone-based screening for atrial fibrillation (eBRAVE-AF) – A pragmatic siteless digital randomized clinical trial

Coronary Atherosclerotic Plaque Activity and Future Coronary Events

Colchicine and Rivaroxaban Plus Aspirin in Patients Hospitalized with COVID-19: A Factorial, Randomized, Open Trial

‘Hot’ Plaque on Noninvasive PET May Presage MI, CV Death: PRE18FFIR

INVICTUS: More Deaths, Stroke With Rivaroxaban in Rheumatic Heart Disease AF

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content